Oral alpha-tocopherol supplementation inhibits lipid oxidation in established human atherosclerotic lesions.
(Q40540239)
scientific article published on November 2003
scientific article published on November 2003
Language:
Current Data About
Oral alpha-tocopherol supplementation inhibits lipid oxidation in established human atherosclerotic lesions.